These researches are referred significantly into the LRRK2 levels and function in blood for patient ordination or authorizing the assumption that PD patients without LRRK2 mutations have raised LRRK2 activity (especially kinase activity that leads to PD pathogenesis). The gene discussed is LRRK2; the disease is Parkinson disease.